COVID19 and Physical and Emotional Wellbeing of HCP (CoPE-HCP)

Queen Mary University of London

Status: Completed

Conditions: Mental Health

Treatments: Other: Questionnaire, same tools as before, with inclusion of PCL5 questionnaire too.; Other: Informed consent; Other: Questionnaire including validated tools such as Patient Health Questionnaire (PHQ-9), the 7-item Generalised Anxiety Disorder (GAD- 7), the 7-item insomnia severity index

Study type: Observational

Funder types: Other

Identifiers

NCT04433260

284686

Details and patient eligibility

About

The current COVID-19 pandemic has affected more than 3 million people worldwide across more than 200 countries.

In the United Kingdom alone, at the end of April, there were almost 160,000 confirmed cases with more than 20,000 deaths. This has undoubtedly had significant physical and economical impact on the public.

Healthcare workers are at high risk of developing life-threatening infectious diseases with increased exposure to patients' blood and bodily fluids. As such, health care workers arguably experience heightened anxiety and are predisposed to greater negative psycho-social impact from the current COVID-19 pandemic.

The aim of this study is to evaluate the physical and psychological impact of COVID-19 on healthcare workers. This will be performed in two phases.

In phase 1, investigators will collect information to evaluate the current psychiatric symptom profile (in particular, screening for anxiety or depression related symptoms), alcohol use, sleep-related complaints and overall well-being among healthcare workers who participate in this survey (with a focus on junior doctors). In addition the association of these mental health and behavioural parameters with the prevalence of stressful occasions, such as long-hours, unpredictability of work / redeployment, availability of personal protection equipment and concerns regarding family/relationship and self will be assessed.

In phase 2, investigators will then reassess for the development or progression of psychiatric symptoms, use of alcohol and other substances, behavioural or interpersonal relationship changes as well as physical well-being at 6 weeks and 4- months. Physical well-being is assessed through the presence of suspected or confirmed COVID-19 infection and absence from work. Specifically, investigators will study the impact of variable provision of personal protection equipment (supply and training), extended working hours, and concern for well-being of family members, on work morale and anxiety levels.

Another aim is also study the longer term mental health consequences of the current pandemic on health care workers.

Enrollment: 1,721 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

1. Aged >=18
2. Electronic consent
3. Either:

a - healthcare workers in contact with patients with confirmed or suspected COVID-19 b - Healthcare staff not having direct patient contact c - Non-healthcare academic staff with no direct patient contact

Exclusion criteria

1. Age<18
2. Individuals not belonging to the 3 cohorts of interest listed in the inclusion criteria.
3. Those who are not able to understand written English will be excluded, indeed by the design and methodology of the study, as the study invite and all other information provided is in English.

Trial design

1,721 participants in 5 patient groups

Cases

Description:

Doctors, nurses and other healthcares ≥ 18 years of age in direct contact with patients potentially infected with COVID-19

Treatment:

Other: Questionnaire including validated tools such as Patient Health Questionnaire (PHQ-9), the 7-item Generalised Anxiety Disorder (GAD- 7), the 7-item insomnia severity index

Other: Informed consent

Other: Questionnaire, same tools as before, with inclusion of PCL5 questionnaire too.

Internal Control

Description:

Healthcare /NHS Administrative staff who are working in the hospital, but not directly in contact with patients potentially infected with COVID-19.

Treatment:

Other: Questionnaire including validated tools such as Patient Health Questionnaire (PHQ-9), the 7-item Generalised Anxiety Disorder (GAD- 7), the 7-item insomnia severity index

Other: Informed consent

Other: Questionnaire, same tools as before, with inclusion of PCL5 questionnaire too.

Population Control

Description:

Non-healthcare/non-NHS academic staff who are not working in the environment where patient exposure is expected.

Treatment:

Other: Questionnaire including validated tools such as Patient Health Questionnaire (PHQ-9), the 7-item Generalised Anxiety Disorder (GAD- 7), the 7-item insomnia severity index

Other: Informed consent

Other: Questionnaire, same tools as before, with inclusion of PCL5 questionnaire too.

Follow-up cases

Description:

Doctors, nurses and other healthcare workers ≥ 18 years of age in direct contact with patients potentially infected with COVID-19 consenting to receive follow-up surveys (n \~ 400)

Treatment:

Other: Questionnaire including validated tools such as Patient Health Questionnaire (PHQ-9), the 7-item Generalised Anxiety Disorder (GAD- 7), the 7-item insomnia severity index

Other: Informed consent

Other: Questionnaire, same tools as before, with inclusion of PCL5 questionnaire too.

Follow-up controls

Description:

Healthcare Administrative staff who are working in the hospital, not at risk of work-related exposure to patients potentially infected with COVID-19 (n\~80)

Treatment:

Other: Questionnaire including validated tools such as Patient Health Questionnaire (PHQ-9), the 7-item Generalised Anxiety Disorder (GAD- 7), the 7-item insomnia severity index

Other: Informed consent

Other: Questionnaire, same tools as before, with inclusion of PCL5 questionnaire too.